Altered signaling in systemic juvenile idiopathic arthritis monocytes

Claudia Macaubas, Elizabeth Wong, Yujuan Zhang, Khoa D. Nguyen, Justin Lee, Diana Milojevic, Susan Shenoi, Anne M. Stevens, Norman Todd Ilowite, Vivian Saper, Tzielan Lee, Elizabeth D. Mellins

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation and arthritis. Monocytes are implicated in sJIA pathogenesis, but their role in disease is unclear. The response of sJIA monocytes to IFN may be dysregulated. We examined intracellular signaling in response to IFN type I (IFNα) and type II (IFNγ) in monocytes during sJIA activity and quiescence, in 2 patient groups. Independent of disease activity, monocytes from Group 1 (collected between 2002 and 2009) showed defective STAT1 phosphorylation downstream of IFNs, and expressed higher transcript levels of SOCS1, an inhibitor of IFN signaling. In the Group 2 (collected between 2011 and 2014), monocytes of patients with recent disease onset were IFNγ hyporesponsive, but in treated, quiescent subjects, monocytes were hyperresponsive to IFNγ. Recent changes in medication in sJIA may alter the IFN hyporesponsiveness. Impaired IFN/pSTAT1 signaling is consistent with skewing of sJIA monocytes away from an M1 phenotype and may contribute to disease pathology.

Original languageEnglish (US)
Pages (from-to)66-74
Number of pages9
JournalClinical Immunology
Volume163
DOIs
StatePublished - Feb 1 2016

Fingerprint

Juvenile Arthritis
Monocytes
Arthritis
Phosphorylation
Pathology
Inflammation
Phenotype

Keywords

  • IFN signaling
  • Juvenile arthritis
  • Monocytes
  • SOCS1

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Macaubas, C., Wong, E., Zhang, Y., Nguyen, K. D., Lee, J., Milojevic, D., ... Mellins, E. D. (2016). Altered signaling in systemic juvenile idiopathic arthritis monocytes. Clinical Immunology, 163, 66-74. https://doi.org/10.1016/j.clim.2015.12.011

Altered signaling in systemic juvenile idiopathic arthritis monocytes. / Macaubas, Claudia; Wong, Elizabeth; Zhang, Yujuan; Nguyen, Khoa D.; Lee, Justin; Milojevic, Diana; Shenoi, Susan; Stevens, Anne M.; Ilowite, Norman Todd; Saper, Vivian; Lee, Tzielan; Mellins, Elizabeth D.

In: Clinical Immunology, Vol. 163, 01.02.2016, p. 66-74.

Research output: Contribution to journalArticle

Macaubas, C, Wong, E, Zhang, Y, Nguyen, KD, Lee, J, Milojevic, D, Shenoi, S, Stevens, AM, Ilowite, NT, Saper, V, Lee, T & Mellins, ED 2016, 'Altered signaling in systemic juvenile idiopathic arthritis monocytes', Clinical Immunology, vol. 163, pp. 66-74. https://doi.org/10.1016/j.clim.2015.12.011
Macaubas C, Wong E, Zhang Y, Nguyen KD, Lee J, Milojevic D et al. Altered signaling in systemic juvenile idiopathic arthritis monocytes. Clinical Immunology. 2016 Feb 1;163:66-74. https://doi.org/10.1016/j.clim.2015.12.011
Macaubas, Claudia ; Wong, Elizabeth ; Zhang, Yujuan ; Nguyen, Khoa D. ; Lee, Justin ; Milojevic, Diana ; Shenoi, Susan ; Stevens, Anne M. ; Ilowite, Norman Todd ; Saper, Vivian ; Lee, Tzielan ; Mellins, Elizabeth D. / Altered signaling in systemic juvenile idiopathic arthritis monocytes. In: Clinical Immunology. 2016 ; Vol. 163. pp. 66-74.
@article{7ade4027de95460988227d311c769c1f,
title = "Altered signaling in systemic juvenile idiopathic arthritis monocytes",
abstract = "Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation and arthritis. Monocytes are implicated in sJIA pathogenesis, but their role in disease is unclear. The response of sJIA monocytes to IFN may be dysregulated. We examined intracellular signaling in response to IFN type I (IFNα) and type II (IFNγ) in monocytes during sJIA activity and quiescence, in 2 patient groups. Independent of disease activity, monocytes from Group 1 (collected between 2002 and 2009) showed defective STAT1 phosphorylation downstream of IFNs, and expressed higher transcript levels of SOCS1, an inhibitor of IFN signaling. In the Group 2 (collected between 2011 and 2014), monocytes of patients with recent disease onset were IFNγ hyporesponsive, but in treated, quiescent subjects, monocytes were hyperresponsive to IFNγ. Recent changes in medication in sJIA may alter the IFN hyporesponsiveness. Impaired IFN/pSTAT1 signaling is consistent with skewing of sJIA monocytes away from an M1 phenotype and may contribute to disease pathology.",
keywords = "IFN signaling, Juvenile arthritis, Monocytes, SOCS1",
author = "Claudia Macaubas and Elizabeth Wong and Yujuan Zhang and Nguyen, {Khoa D.} and Justin Lee and Diana Milojevic and Susan Shenoi and Stevens, {Anne M.} and Ilowite, {Norman Todd} and Vivian Saper and Tzielan Lee and Mellins, {Elizabeth D.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.clim.2015.12.011",
language = "English (US)",
volume = "163",
pages = "66--74",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Altered signaling in systemic juvenile idiopathic arthritis monocytes

AU - Macaubas, Claudia

AU - Wong, Elizabeth

AU - Zhang, Yujuan

AU - Nguyen, Khoa D.

AU - Lee, Justin

AU - Milojevic, Diana

AU - Shenoi, Susan

AU - Stevens, Anne M.

AU - Ilowite, Norman Todd

AU - Saper, Vivian

AU - Lee, Tzielan

AU - Mellins, Elizabeth D.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation and arthritis. Monocytes are implicated in sJIA pathogenesis, but their role in disease is unclear. The response of sJIA monocytes to IFN may be dysregulated. We examined intracellular signaling in response to IFN type I (IFNα) and type II (IFNγ) in monocytes during sJIA activity and quiescence, in 2 patient groups. Independent of disease activity, monocytes from Group 1 (collected between 2002 and 2009) showed defective STAT1 phosphorylation downstream of IFNs, and expressed higher transcript levels of SOCS1, an inhibitor of IFN signaling. In the Group 2 (collected between 2011 and 2014), monocytes of patients with recent disease onset were IFNγ hyporesponsive, but in treated, quiescent subjects, monocytes were hyperresponsive to IFNγ. Recent changes in medication in sJIA may alter the IFN hyporesponsiveness. Impaired IFN/pSTAT1 signaling is consistent with skewing of sJIA monocytes away from an M1 phenotype and may contribute to disease pathology.

AB - Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation and arthritis. Monocytes are implicated in sJIA pathogenesis, but their role in disease is unclear. The response of sJIA monocytes to IFN may be dysregulated. We examined intracellular signaling in response to IFN type I (IFNα) and type II (IFNγ) in monocytes during sJIA activity and quiescence, in 2 patient groups. Independent of disease activity, monocytes from Group 1 (collected between 2002 and 2009) showed defective STAT1 phosphorylation downstream of IFNs, and expressed higher transcript levels of SOCS1, an inhibitor of IFN signaling. In the Group 2 (collected between 2011 and 2014), monocytes of patients with recent disease onset were IFNγ hyporesponsive, but in treated, quiescent subjects, monocytes were hyperresponsive to IFNγ. Recent changes in medication in sJIA may alter the IFN hyporesponsiveness. Impaired IFN/pSTAT1 signaling is consistent with skewing of sJIA monocytes away from an M1 phenotype and may contribute to disease pathology.

KW - IFN signaling

KW - Juvenile arthritis

KW - Monocytes

KW - SOCS1

UR - http://www.scopus.com/inward/record.url?scp=84953304113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953304113&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2015.12.011

DO - 10.1016/j.clim.2015.12.011

M3 - Article

VL - 163

SP - 66

EP - 74

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

ER -